Cover Image

Expression of soluble TGF-ß receptor II by recombinant Vaccinia virus enhances E7 specific immunotherapy of HPV16 tumors

Bibliographic Details
Main Authors:	Krystofova, J. (Author), Babiarova, K. (Author), Kutinova, L. (Author), Hainz, P. (Author), Chlanda, P. (Author), Nemeckova, S. (Author), Samkova, Z. (Author), Zurkova, К. (Author)
Format:	Article
Language:	English

Similar Items

HEPATITIS B VIRUS CORE - PRES2 PARTICLES EXPRESSED BY RECOMBINANT VACCINIA VIRUS
by: Kunke, D., et al.

Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells
by: Němečková, Š., et al.

TEMPERATURE MUTANTS AND RECOMBINANTS OF VACCINIA VIRUS. II. RECOMBINATION BETWEEN TEMPERATURE MUTANTS
by: Fidziańska, E.

Combination of Intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules
by: Mackova, J., et al.

Immunization with Varicella-zoster virus glycoprotein E expressing vectors: comparison of antibody response to DNA vaccine and recombinant Vaccinia virus
by: Kutinová, L., et al.